DELRAY BEACH, Fla., June 3, 2025 -- The global Digital Pathology Market, valued at US$1.29 billion in 2024 stood at US$1.46 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.75 billion by the end of the period. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.
Collaborations have compelled the market, which is one of the key factors in play. In March 2024, Amazon Web Services (AWS) (US) and Koninklijke Philips (Netherlands) collaborated to provide cloud-based digital pathology solutions. The intent behind the collaboration was to enhance care delivery by boosting workflow efficiency, improving data security, and facilitating smooth integration with existing healthcare IT infrastructure.
As digital pathology becomes more widely adopted, healthcare organizations are increasingly drawing insights from early implementers to guide their own strategies. However, the market still faces challenges such as a shortage of trained pathologists, high initial investment requirements, and uncertainty around reimbursement policies, which may hinder widespread deployment in some regions.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=844
Browse in-depth TOC on "Digital Pathology Market"
400 - Tables
400 - Figures
350 - Pages
By type, the human pathology segment is expected to experience the fastest growth rate by type throughout the forecast period. The market segmentation of veterinary and human pathology will remain relatively unchanged. Indeed, the human pathology segment is growing rapidly due to the increasing desire for accurate, fast, and effective diagnostic methods. The obvious need for accurate pathology assessments to support treatment planning is becoming progressively highlighted by the rise of chronic diseases such as cancer. Compared to traditional methods, digital pathology enables sophisticated analysis of images, utilizes less physical storage space, offers more efficient slide retrieval, and simplified image collaboration and sharing to obtain second opinions.
By end user, the pharmaceutical & biotechnology companies segment dominated the market in 2024 due to growing drug research, discovery, and personalized medicine use of digital pathology. Digital pathology technology enables companies to use high-resolution images and automated analysis. This speeds up screening, improves the evaluation of tissue samples, identifies drug candidates, and enables high-throughput screening.
By geography, North America led the global digital pathology market in 2024. Its robust investment in health technologies, high rate of chronic disease instances such as cancer, particularly in the US, and developed health infrastructure support this leadership position. Additionally, the region's concentration of key research institutes and companies fosters sustained innovation and the use of digital pathology solutions.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=844
Prominent players in the digital pathology market include Huron Digital Pathology (Canada), Hologic, Inc. (US), Corista (US), Indica Labs Inc. (US), 3DHISTECH (Hungary), Objective Pathology Services Limited (Canada), OptraSCAN (US), Sectra AB (Sweden), Akoya Biosciences, Inc. (US), Hamamatsu
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
